|
MolProbity: More and better reference data for improved all-atom structure validation: PROTEIN SCIENCE.ORG
|
journal
|
November 2017 |
|
Rosetta3: An Object-Oriented Software Suite for the Simulation and Design of Macromolecules
|
book
|
January 2011 |
|
Structure of Bax
|
journal
|
November 2000 |
|
The Combined Functions of Proapoptotic Bcl-2 Family Members Bak and Bax Are Essential for Normal Development of Multiple Tissues
|
journal
|
December 2000 |
|
Bax Crystal Structures Reveal How BH3 Domains Activate Bax and Nucleate Its Oligomerization to Induce Apoptosis
|
journal
|
January 2013 |
|
A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
|
journal
|
June 2014 |
|
Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer
|
journal
|
September 2018 |
|
Computational Design of a Protein-Based Enzyme Inhibitor
|
journal
|
September 2013 |
|
Potent and Specific Peptide Inhibitors of Human Pro-Survival Protein Bcl-xL
|
journal
|
March 2015 |
|
A Stapled BID BH3 Helix Directly Binds and Activates BAX
|
journal
|
October 2006 |
|
The X-Ray Structure of a BAK Homodimer Reveals an Inhibitory Zinc Binding Site
|
journal
|
December 2006 |
|
To Trigger Apoptosis, Bak Exposes Its BH3 Domain and Homodimerizes via BH3:Groove Interactions
|
journal
|
May 2008 |
|
Bak Activation for Apoptosis Involves Oligomerization of Dimers via Their α6 Helices
|
journal
|
November 2009 |
|
A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria
|
journal
|
November 2011 |
|
Bak Core and Latch Domains Separate during Activation, and Freed Core Domains Form Symmetric Homodimers
|
journal
|
September 2014 |
|
Inhibition of Pro-Apoptotic BAX by a Noncanonical Interaction Mechanism
|
journal
|
March 2015 |
|
Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based Design
|
journal
|
November 2017 |
|
Structure of detergent-activated BAK dimers derived from the inert monomer
|
journal
|
May 2021 |
|
Pharmacological Targeting of Executioner Proteins: Controlling Life and Death
|
journal
|
May 2021 |
|
Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor
|
journal
|
March 2020 |
|
BCL-2 family proteins: changing partners in the dance towards death
|
journal
|
November 2017 |
|
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
|
journal
|
January 2015 |
|
BAX activation is initiated at a novel interaction site
|
journal
|
October 2008 |
|
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|
journal
|
January 2013 |
|
Isolating and engineering human antibodies using yeast surface display
|
journal
|
July 2006 |
|
BID-induced structural changes in BAK promote apoptosis
|
journal
|
April 2013 |
|
Mcl-1 and Bcl-xL sequestration of Bak confers differential resistance to BH3-only proteins
|
journal
|
February 2018 |
|
VDAC2 loss elicits tumour destruction and inflammation for cancer therapy
|
journal
|
March 2025 |
|
Covalent inhibition of pro-apoptotic BAX
|
journal
|
January 2024 |
|
SNAC-tag for sequence-specific chemical protein cleavage
|
journal
|
March 2019 |
|
BAK core dimers bind lipids and can be bridged by them
|
journal
|
September 2020 |
|
Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario
|
journal
|
May 2006 |
|
The multidomain proapoptotic molecules Bax and Bak are directly activated by heat
|
journal
|
December 2005 |
|
Mitochondrial Release of Pro-apoptotic Proteins
|
journal
|
January 2005 |
|
The Pro-Apoptotic Proteins, Bid and Bax, Cause a Limited Permeabilization of the Mitochondrial Outer Membrane That Is Enhanced by Cytosol
|
journal
|
November 1999 |
|
A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation
|
journal
|
January 2008 |
|
Enrich: software for analysis of protein function by enrichment and depletion of variants
|
journal
|
October 2011 |
|
TM-align: a protein structure alignment algorithm based on the TM-score
|
journal
|
April 2005 |
|
Phaser crystallographic software
|
journal
|
July 2007 |
|
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
|
Solving structures of protein complexes by molecular replacement with Phaser
|
journal
|
December 2006 |
|
XDS
|
journal
|
January 2010 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
Overview of the CCP 4 suite and current developments
|
journal
|
March 2011 |
|
Towards automated crystallographic structure refinement with phenix.refine
|
journal
|
March 2012 |
|
How good are my data and what is the resolution?
|
journal
|
June 2013 |
|
MX2: a high-flux undulator microfocus beamline serving both the chemical and macromolecular crystallography communities at the Australian Synchrotron
|
journal
|
April 2018 |
|
Bax, Bak and beyond — mitochondrial performance in apoptosis
|
journal
|
September 2017 |
|
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
|
journal
|
April 2001 |
|
Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin
|
journal
|
May 2011 |
|
RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite
|
journal
|
June 2011 |
|
Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice
|
journal
|
August 2013 |
|
Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer
|
journal
|
November 2016 |